The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

NRIX FINANCIAL STATEMENTS

Nurix Therapeutics Inc — balance sheet, income statement and cash flow trends

NRIXNurix Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue36.8 M $Gross Profit-60.9 M $ · -166%Operating Income-361.2 M $ · -982%Pre-tax Income-341.6 M $ · -929%Net Income to Owners-341.4 M $ · -928%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue36.8 M $-58.4%
Gross Profit-60.9 M $—
Operating Income-361.2 M $—
EBITDA-319.7 M $—
Net Income to Owners-341.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets535.5 M
  • Equity402.6 M $75%
  • Current Liabilities72 M $13%
  • Long-term Liabilities60.9 M $11%

Key Figures

YoY change
Total Assets535.5 M $-9.5%
Total Liabilities132.9 M $-7.7%
Total Equity402.6 M $-10.0%
Cash & ST Investments443.5 M $-8.7%
Total Debt58.1 M $+12.0%
Net Debt-9.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-300 M-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-300 M-200 M-100 M0-293.7 M $Operating20 M $Investing257.2 M $Financing-16.5 M $Net Change

Key Figures

YoY change
Operating Cash Flow-293.7 M $—
Capital Expenditures10.8 M $+2.0%
Free Cash Flow-304.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NRIX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.